Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
1.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 1515-1519, 2013.
Article Dans Chinois | WPRIM | ID: wpr-231653

Résumé

<p><b>OBJECTIVE</b>To explore the possible angiogenesis mechanism of Huazhuo Jiedu Hewei Recipe (HJHR) in preventing and treating precancerous lesions of gastric cancer (PLGC).</p><p><b>METHODS</b>Totally 66 Wistar rats were randomly divided into 6 groups, i.e., the normal control group, the model group, the retinoic acid (RA) group, the high dose HJHR group, the middle dose HJHR group, the low dose HJHR group, 11 in each group. PLGC model was duplicated by inserting a spring with Helicobacter. Corresponding medicines were administered to rats in each medicated group once daily by gastrogavage, 2 mL each time for 12 successive weeks. The effect of HJHR on hypoxia induced factor (HIF-1alpha) and vascular endothelial growth factor (VEGF) of PLGC in chronic atrophic gastritis (CAG) rats' gastric mucosa was observed by immunohistochemical assay and Western blot method.</p><p><b>RESULTS</b>Compared with the normal control group, the expression of VEGF and HIF-1alpha increased in the model group (P < 0.05). Compared with the model group, the expression of VEGF and HIF-1alpha decreased in each medicated group (P < 0.05). Besides, they were lower in the high and middle dose HJHR groups than in the RA group and the low dose HJHR group (P < 0. 05). There was no statistical difference between the low dose HJHR group and the RA group (P > 0.05).</p><p><b>CONCLUSION</b>HJHR could prevent and treat PLGC of CAG rats possibly through decreasing the expression of HIF-1alpha and VEGF in a dose-dependent manner.</p>


Sujets)
Animaux , Mâle , Rats , Médicaments issus de plantes chinoises , Utilisations thérapeutiques , Muqueuse gastrique , Métabolisme , Gastrite , Métabolisme , Microbiologie , Helicobacter , Sous-unité alpha du facteur-1 induit par l'hypoxie , Métabolisme , Néovascularisation pathologique , États précancéreux , Traitement médicamenteux , Métabolisme , Rat Wistar , Tumeurs de l'estomac , Traitement médicamenteux , Métabolisme , Facteur de croissance endothéliale vasculaire de type A , Métabolisme
SÉLECTION CITATIONS
Détails de la recherche